The TNFAIP3 gene makes a protein called A20, which acts like a brake on inflammation and helps the immune system switch off after a threat has passed. If this gene does not work properly, immune signals can stay too active and may lead to repeated fevers, mouth ulcers, joint pain, bowel inflammation, or a condition called HA20. This gene plays an important role in keeping immune responses balanced. TNFAIP3 is mainly known in medical genetics rather than popular culture.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or to regulate processes in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others are mainly involved in controlling when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, and medications. To go into this topic further, you can find more in the LearnHub.
Overview
TNFAIP3Gene function
What if the gene works
Your immune system uses the TNFAIP3 gene to turn down inflammation after a threat has been recognized. This helps keep immune signals balanced and protects tissues from unnecessary damage.
Risk
What if the gene does not work
Variants that reduce the TNFAIP3 gene's function can cause A20 haploinsufficiency, with recurrent mouth or genital ulcers, fevers, arthritis, bowel inflammation, and other autoimmune features. Milder or more severe variants can affect when symptoms begin and how strongly they appear.
Treatment
What does that mean for your treatment
No treatment or drug choice guideline specific to pathogenic variants in the TNFAIP3 gene is currently established. Care is usually tailored to the person’s inflammatory symptoms, and A20-related signaling is being studied as a possible drug target in autoinflammatory disease and some cancers.
Conditions associated with TNFAIP3
Gene function
What if the gene works
Inflammation needs careful timing so your body can react, then settle back down. In day to day immune activity, the TNFAIP3 gene helps control inflammation by turning signals down once they are no longer needed. This supports a response that is active when useful and quieter when the job is done.
The TNFAIP3 gene helps switch off immune signals after they have been turned on. This keeps inflammation better timed and more controlled during normal healing and defense.
Its protein adjusts small control tags on other proteins, which changes how long immune messages stay active. This is one of the main ways cells shut down signaling once a message has been delivered.
Cells often make more A20 protein from the TNFAIP3 gene after they sense inflammatory cues. That built in feedback helps the immune response settle instead of staying switched on longer than needed.
The TNFAIP3 gene also helps manage signals linked to cell survival during immune stress. This supports steady tissue function while the body responds to everyday challenges.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help explain normal variation among people, including differences in appearance, metabolism, or the way the body responds to environmental factors. Many variants do not cause any noticeable effect and are simply part of natural genetic diversity. In some situations, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many TNFAIP3 gene variants affect the A20 protein by making it shorter, less stable, or less able to interact with the cell tags that control inflammatory signaling. Some changes only partly weaken one working region, while more severe variants can stop one copy from producing a usable protein. This stronger loss of function can leave inflammatory pathways active for longer and may be linked to earlier or more pronounced features of the condition associated with the TNFAIP3 gene.
How variants are linked to conditions
Pathogenic variants in the TNFAIP3 gene cause haploinsufficiency of A20, an inherited inflammatory condition often involving repeated mouth or genital ulcers, fevers, bowel inflammation, skin rashes, and joint pain. In scientific studies, TNFAIP3 gene variants and autoimmune disease have also been linked at a population level, including conditions such as lupus and rheumatoid arthritis. These broader associations can influence risk, but they do not mean someone will definitely develop a specific illness.
A variant is not necessarily a diagnosis
Variants in genes are a usual part of human biology and are common across the general population. Most have no direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors also contribute. In some situations, though, one well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For disease-causing changes in the TNFAIP3 gene, the main risk comes from inheriting the variant, and day-to-day factors are not known to reliably prevent the condition. Symptoms can still vary widely between family members, and infections or other immune stress can sometimes trigger flares or make inflammation more noticeable.
Inheritance of TNFAIP3 variants
TNFAIP3-related conditions are usually inherited in an autosomal dominant pattern. This means a parent with a disease-causing variant in the TNFAIP3 gene has a 50% chance of passing it to each child, regardless of sex. In many families, TNFAIP3 inheritance is vertical, with the variant seen across generations. Some people have a new, de novo variant in the TNFAIP3 gene, meaning it started in them and was not inherited from either parent.
What does my TNFAIP3 result mean for my family?
For TNFAIP3, a disease-causing result is usually linked to a dominant family pattern, which means close relatives such as parents, brothers, sisters, and children may also carry the same change and may want to learn whether it applies to them. In some families, the change is new in the affected person, so it did not come from either parent. The exact family impact depends on whether the result is a clearly disease-causing change tied to TNFAIP3-related inflammation.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for TNFAIP3 variants usually uses a blood or saliva sample to read the TNFAIP3 gene and look for changes linked to disease. Results can show whether a pathogenic variant is present, absent, or uncertain, and they are interpreted alongside your symptoms and family history.
When should I consider getting a genetic test?
Consider TNFAIP3 testing when there are repeated unexplained inflammatory flares from childhood or early adult life, such as fevers, painful mouth or genital sores, bowel inflammation, or several autoimmune problems. It can also make sense when close relatives have similar symptoms, because harmful changes in TNFAIP3 can cause an inherited immune condition.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but the amount it reveals depends on the condition and on the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and is most helpful when considered together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help make individual experiences easier to understand.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This can change how the body breaks down a drug, how strongly the drug acts, or how sensitive someone is to side effects. Because these differences are common, the same treatment may work well for one person, work less well for another, or feel harder to tolerate.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. It focuses on the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works and how the body processes it. This understanding can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the TNFAIP3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choices, so questions about side effects, a treatment that is not helping, or starting a new medicine are best discussed with your doctor. TNFAIP3 has been studied in research on how some immune-related treatments work in inflammatory conditions, but those findings are not used routinely in everyday care.
History
TNFAIP3 entered genetics through studies of inflammation in the early 1990s, when researchers identified a gene switched on by tumor necrosis factor, a signal the immune system uses during stress and infection. It was first called A20, and that early name is still widely used in research. From these first observations, research expanded steadily. Scientists later recognized that changes in the TNFAIP3 gene could contribute to immune driven conditions, which made it an important part of work on autoimmunity and inflammatory disease. More recently, rare inherited variants in the TNFAIP3 gene were linked to a condition called A20 haploinsufficiency, helping connect earlier lab findings with patterns seen in families and clinical care.